MDR class IIa approved
CE (0344) certified
ISO 13485 certified
ISO 13485 certified
ISO 27001 certified
MDR class IIa approved
TGA approved
MHRA approved
Business & integration partners
Research partners
RetCAD allows for accurate diagnosis and efficient screening for eye diseases. Thirona’s expertise in artificial intelligence and clinical knowledge make them a valuable partner for bringing AI tools to the clinical routine.
Dr. Toam Katz
Ophthalmologist and senior physician
University Medical Center Hamburg-Eppendorf (UKE)
What I really like about RetCAD is the accuracy of the software in combination with the simplicity of use. Moreover, I greatly appreciate the level of service support from Thirona.
Dr. Dave Block
Ophthalmologist and owner
Eye Care
iCare ILLUME based screening solution combining DRSplus for image acquisition and RetCAD software for image analysis can be integrated into clinical daily practice by simplifying and making the screening process more efficient for both patients and eye-care providers.
Dr. Alberto Piatti
Ophthalmologist
ASL TO5
Next level eye care diagnostics
With global costs of vision loss estimated to be nearly $3 trillion and up to 80% cases of retinal diseases causing visual impairment or blindness that can often be prevented if detected timely, artificial intelligence opens up a whole new possibilities in eye care. Imaging is non-invasive and reliable screening method but requires expertise to analyse/read the acquired images. Using artificial intelligence, this can be done quickly, yet accurately.
RetCAD™ uses state-of-the-art deep learning and computer vision technology utilizing a large amount of retinal images in order to provide precisely quantified clinical evidence. The software assists eye care specialists in early diagnosis and grading of vision threatening diseases, such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). Simplified visualization of the scan analysis with heat maps help improve patient engagement and prevent severe eyesight problems and blindness.
Applications
Large national screening programs and research
Helping more patients faster
With use of artificial intelligence healthcare organisations can perform mass examinations on a large scale with very accurate results, on pair or even surpassing the performance of traditional vision screening methods.
Having every patient scan instantly analyzed with a clinically validated software system trained to detect typical disease patterns, RetCAD™ allows for screening big populations fast while providing highly reliable results.
Optical retail and digital healthcare services
Instant detection of early symptoms
Detection for Diabetic Retinopathy and Age-related Macular Degeneration can be now performed by opticians using artificial intelligence to help spot early signs of the diseases and save diagnostics costs.
RetCAD™ software integrated with a fundus camera ensures reliable and consistent performance, irrespective of the reader, workload or time of day. Disease symptoms detection takes only few minutes and provides validated results instantly.
Medical centers and eye care specialists
Fast and effective patient triaging
The ability to prioritize faster and objectively which patients need immediate follow-up, opens truly whole new possibilities in eye care. Ophthalmologists can now help more patients quicker by identifying severe symptoms faster.
How it works
With today’s digital color fundus cameras, one or multiple images can be acquired from a patient within seconds and are presented on the operator’s computer screen. RetCAD™ will automatically start analysing any acquired color fundus image and provide the user with a score and heat map that indicate referable disease symptoms.
Download the white paper to learn more on the general principles of the software and the performance in comparison to human experts, on various datasets.
Papers & Publications
Learn more about the performance of RetCAD™ through below validation studies.
